Home › NY › Syracuse › NPI 1578554630

SUNY Health Science Center at Syracuse

SUNY Health Science Center at Syracuse was paid $179.83M by Medicaid between Jan 2018 and Dec 2024, across 768 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 6.6% of everything it billed.

33Billing provider infoSUNY HEALTH SCIENCE CENTER AT SYRACUSE
SYRACUSE, NY 13210

33aNPI1578554630assigned 10/28/2005

33bProvider typePeritoneal Dialysis Registered Nurse

28Total paid$179.83M

24GClaims3,290,130

24DCodes billed768

24AFirst – last monthJan 2018 – Dec 2024

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,960	$260K
2019	179,464	$9.27M
2020	523,025	$28.09M
2021	633,998	$34.53M
2022	623,262	$34.90M
2023	713,557	$38.68M
2024incomplete	611,864	$34.09M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J9271	Injection, pembrolizumab, 1 mg	6.6%	1,635	1,325	$11.84M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.8%	60,923	58,286	$10.48M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.1%	49,869	47,565	$9.11M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.3%	46,796	40,492	$7.69M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.0%	41,010	36,760	$7.11M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.9%	29,408	24,953	$5.23M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	2.8%	67,035	62,824	$5.01M
41899	Unlisted procedure, dentoalveolar structures	2.7%	4,428	4,418	$4.94M
96361	Intravenous infusion, hydration; each additional hour	2.7%	20,507	17,412	$4.87M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.3%	29,295	11,432	$4.18M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.3%	21,524	20,179	$4.11M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.3%	28,469	27,131	$4.10M

756 more codes

87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.0%	60,727	$3.60M
70450	Computed tomography, head or brain; without contrast material	1.5%	8,461	$2.75M
93976		1.5%	5,593	$2.61M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.3%	17,217	$2.34M
G0378	Hospital observation service, per hour	1.3%	10,579	$2.32M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	9,445	$2.29M
80053	Comprehensive metabolic panel	1.2%	117,489	$2.11M
87486		1.2%	60,857	$2.08M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.1%	9,927	$1.90M
D0999	Unspecified diagnostic procedure, by report	1.0%	12,686	$1.88M
76770		1.0%	6,558	$1.85M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	11,069	$1.78M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	9,280	$1.76M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	46,269	$1.75M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	9,808	$1.74M
90834	Psychotherapy session, about 45 minutes	<1%	11,117	$1.66M
99215	Doctor's office visit, returning patient (complex)	<1%	8,906	$1.65M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,470	$1.56M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,277	$1.42M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	1,518	$1.41M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,692	$1.29M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	55,328	$1.27M
96415		<1%	2,436	$1.24M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,203	$1.22M
87581		<1%	60,871	$1.18M
96367		<1%	10,855	$1.08M
80048	Basic metabolic panel (calcium, ionized)	<1%	54,049	$1.06M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,316	$1.01M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	34,872	$1.00M
36430		<1%	2,728	$926K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,738	$922K
36415	Collection of venous blood by venipuncture	<1%	124,375	$867K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	616	$768K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	34,851	$761K
12001		<1%	1,662	$749K
97162		<1%	4,365	$712K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	21,954	$692K
92567		<1%	5,799	$689K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,033	$684K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,704	$678K
12011		<1%	1,509	$667K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	1,871	$626K
70498		<1%	1,934	$618K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	11,685	$610K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,443	$606K
77386		<1%	5,867	$556K
95782		<1%	695	$539K
97161		<1%	3,710	$529K
12002		<1%	1,061	$480K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	729	$474K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,904	$473K
90791	Psychiatric diagnostic evaluation	<1%	1,887	$447K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	2,564	$435K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	3,591	$425K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	1,970	$418K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	7,917	$411K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	10,766	$406K
87536		<1%	4,839	$401K
90836		<1%	4,619	$387K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,223	$386K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	20,125	$371K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	1,806	$368K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	11,891	$368K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	229	$352K
86850		<1%	16,160	$350K
59025	Fetal non-stress test	<1%	1,560	$340K
84443	Thyroid stimulating hormone (TSH)	<1%	44,682	$332K
99203	Doctor's office visit, new patient (routine)	<1%	1,633	$331K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,071	$327K
82803		<1%	16,086	$326K
70491		<1%	1,223	$314K
90837	Psychotherapy session, about an hour	<1%	1,498	$311K
90832	Psychotherapy session, about 30 minutes	<1%	2,412	$307K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	132,439	$302K
86901		<1%	16,531	$299K
99204	Doctor's office visit, new patient (more involved)	<1%	1,489	$299K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	12,409	$297K
10060		<1%	841	$290K
97116		<1%	3,164	$289K
96417		<1%	3,311	$280K
88185		<1%	1,956	$279K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,059	$268K
83036	Hemoglobin; glycosylated (A1C)	<1%	32,281	$265K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,801	$262K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	2,393	$252K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	19,029	$252K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	9,010	$251K
80061	Lipid panel	<1%	24,633	$248K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,176	$244K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	233	$241K
70486		<1%	2,248	$234K
92526		<1%	1,528	$230K
74183		<1%	699	$220K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	1,649	$220K
86900		<1%	16,559	$219K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	7,625	$212K
14040		<1%	171	$211K
80076		<1%	18,301	$207K
J9035	Injection, bevacizumab, 10 mg	<1%	54	$206K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	240	$204K
G0390	Trauma response team associated with hospital critical care service	<1%	114	$202K
99205	Prolong outpt/office vis	<1%	1,012	$202K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,573	$201K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	9,050	$195K
76830	Ultrasound, transvaginal	<1%	5,729	$193K
83880		<1%	5,198	$192K
77336		<1%	2,837	$191K
54161		<1%	265	$190K
94060		<1%	2,658	$184K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	3,643	$182K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	928	$181K
36591		<1%	7,328	$181K
86235		<1%	9,701	$180K
84439		<1%	21,614	$174K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	12,620	$173K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	4,297	$169K
96416		<1%	312	$169K
J1437	Injection, ferric derisomaltose, 10 mg	<1%	417	$169K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,147	$168K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	7,940	$167K
77334		<1%	1,109	$167K
97535	Self-care/home management training, each 15 minutes	<1%	2,158	$167K
80047		<1%	6,991	$167K
93970		<1%	288	$164K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	800	$164K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	2,770	$158K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,054	$156K
54640		<1%	151	$155K
71250		<1%	1,636	$155K
87088		<1%	27,467	$154K
92587		<1%	3,171	$153K
86481		<1%	3,392	$151K
J1756	Injection, iron sucrose, 1 mg	<1%	3,220	$150K
97166		<1%	1,307	$148K
72141		<1%	452	$147K
92610		<1%	1,034	$146K
87660		<1%	12,893	$143K
82728		<1%	15,864	$143K
97163		<1%	715	$142K
83655		<1%	11,040	$142K
90651		<1%	1,001	$142K
70496		<1%	1,783	$140K
40806		<1%	124	$139K
44970		<1%	64	$137K
86780		<1%	15,558	$137K
92557		<1%	2,124	$137K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	2,516	$136K
87480		<1%	12,425	$136K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,483	$135K
81229		<1%	109	$134K
83970		<1%	3,074	$130K
86003		<1%	3,716	$129K
87510		<1%	11,947	$129K
86480		<1%	2,401	$128K
92551		<1%	2,011	$127K
84702		<1%	29,949	$126K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	551	$119K
99407		<1%	1,307	$116K
72156		<1%	370	$114K
96158		<1%	1,388	$114K
85027		<1%	41,488	$111K
99442		<1%	875	$110K
D0120	Dental checkup, returning patient	<1%	6,927	$110K
93971		<1%	1,337	$109K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	71	$109K
83516		<1%	3,087	$107K
96156		<1%	618	$107K
96368		<1%	2,701	$106K
90715		<1%	4,006	$105K
82947		<1%	40,077	$104K
76801		<1%	1,794	$103K
77065	Tomosynthesis, mammo	<1%	1,386	$102K
76942		<1%	621	$100K
72131		<1%	1,587	$100K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	34,905	$99K
82607		<1%	9,511	$98K
76642		<1%	2,243	$95K
16020		<1%	203	$94K
84403		<1%	4,330	$93K
31575		<1%	666	$92K
71046	Radiologic examination, chest; 2 views	<1%	14,906	$90K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,181	$89K
29125		<1%	366	$89K
D1110	Prophylaxis - adult	<1%	5,181	$87K
97165		<1%	1,153	$85K
41010		<1%	108	$85K
96040		<1%	2,258	$85K
88342		<1%	1,999	$84K
82784		<1%	9,655	$83K
41115		<1%	80	$83K
86803		<1%	11,116	$82K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	403	$82K
87507		<1%	1,074	$82K
76937		<1%	510	$81K
87077		<1%	15,099	$81K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,231	$81K
81003		<1%	60,877	$81K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,844	$80K
36561		<1%	72	$80K
D9999	Unspecified adjunctive procedure, by report	<1%	464	$79K
J0897	Injection, denosumab, 1 mg	<1%	90	$79K
77300		<1%	747	$79K
87806		<1%	4,215	$78K
90686		<1%	4,365	$77K
85610		<1%	19,570	$77K
95816		<1%	1,565	$75K
87340		<1%	9,433	$75K
72197		<1%	210	$74K
97803		<1%	3,702	$74K
76641		<1%	1,816	$73K
92523		<1%	334	$72K
88307		<1%	990	$71K
95812		<1%	1,917	$70K
86160		<1%	7,490	$69K
77049		<1%	187	$68K
82570		<1%	15,413	$68K
88112		<1%	1,278	$67K
77001		<1%	241	$67K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	311	$66K
92579		<1%	1,022	$66K
87522	Neg quan hep c or qual rna	<1%	1,551	$66K
86360		<1%	1,905	$65K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	1,638	$62K
84202		<1%	6,613	$60K
96409		<1%	882	$60K
77066	Tomosynthesis, mammo	<1%	921	$59K
88304		<1%	2,376	$58K
86902		<1%	1,590	$57K
20610		<1%	233	$57K
72128		<1%	1,303	$57K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,440	$57K
74174		<1%	244	$56K
86920		<1%	1,531	$55K
83540		<1%	15,141	$54K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	17,041	$53K
99443		<1%	634	$53K
83735		<1%	18,819	$53K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	391	$53K
81001		<1%	21,408	$52K
83550		<1%	14,857	$52K
86618		<1%	5,187	$51K
82670		<1%	2,292	$51K
92582		<1%	806	$51K
76536		<1%	1,599	$50K
96411		<1%	1,874	$49K
96112		<1%	289	$48K
86762		<1%	3,669	$48K
86140		<1%	21,608	$47K
95811		<1%	65	$47K
74178		<1%	345	$46K
86923		<1%	1,383	$46K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,528	$46K
85652		<1%	27,004	$44K
97802		<1%	1,704	$44K
96450		<1%	66	$44K
62270		<1%	128	$43K
83021		<1%	2,168	$43K
84146		<1%	2,194	$42K
69210		<1%	747	$42K
88341		<1%	1,103	$41K
25605		<1%	84	$41K
83001		<1%	2,424	$40K
84402		<1%	1,816	$40K
82746		<1%	4,330	$39K
76857		<1%	860	$39K
87529		<1%	1,351	$39K
86356		<1%	1,397	$38K
90792	Psychiatric diagnostic evaluation with medical services	<1%	175	$38K
95886		<1%	271	$37K
84153		<1%	2,722	$37K
19083		<1%	25	$36K
86359		<1%	1,889	$36K
83002		<1%	2,052	$36K
88184		<1%	1,475	$36K
40819		<1%	41	$35K
87501		<1%	907	$35K
86038		<1%	7,316	$35K
94760		<1%	5,411	$34K
80197		<1%	3,611	$33K
71045	Radiologic examination, chest; single view	<1%	14,021	$33K
76870		<1%	1,534	$33K
77080		<1%	613	$32K
72157		<1%	111	$32K
84156		<1%	9,407	$32K
86706		<1%	4,137	$31K
99173		<1%	1,371	$31K
85007		<1%	24,445	$30K
87205		<1%	15,976	$30K
82043		<1%	5,987	$30K
82533		<1%	2,016	$30K
86147		<1%	3,037	$30K
47562		<1%	12	$30K
86376		<1%	2,192	$30K
87186		<1%	7,696	$30K
D0330	Panoramic radiographic image	<1%	1,447	$29K
87070		<1%	5,791	$29K
84100		<1%	10,956	$29K
92553		<1%	392	$29K
95819		<1%	632	$29K
77062		<1%	556	$28K
77412		<1%	447	$28K
J2997	Injection, alteplase recombinant, 1 mg	<1%	287	$28K
96375	Therapeutic injection; each additional sequential IV push	<1%	21,417	$28K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,111	$28K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	10,169	$28K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	62	$27K
87641		<1%	1,320	$27K
84484		<1%	20,334	$26K
84207		<1%	994	$26K
76882		<1%	764	$26K
83690		<1%	19,808	$26K
87640		<1%	1,322	$26K
82565		<1%	5,816	$26K
93351		<1%	195	$26K
86787		<1%	3,294	$25K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,868	$25K
87150		<1%	710	$25K
74420		<1%	123	$25K
80069		<1%	2,291	$25K
92522		<1%	106	$24K
86225		<1%	5,334	$24K
85730		<1%	9,242	$24K
88237		<1%	241	$24K
74018		<1%	5,438	$24K
86146		<1%	2,756	$24K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	7,863	$23K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	71	$23K
94726		<1%	1,241	$23K
82010		<1%	2,259	$23K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	3,249	$23K
84305		<1%	1,152	$22K
D0140	Limited oral evaluation - problem focused	<1%	1,272	$22K
70487		<1%	65	$21K
86141		<1%	2,123	$21K
77061		<1%	530	$21K
96402		<1%	390	$21K
73130		<1%	3,811	$21K
90677		<1%	769	$21K
86431		<1%	4,411	$20K
54163		<1%	27	$20K
J8540	Dexamethasone, oral, 0.25 mg	<1%	2,165	$20K
84550		<1%	5,111	$20K
86200		<1%	857	$20K
51798		<1%	92	$20K
97164		<1%	152	$20K
95715		<1%	92	$20K
84460		<1%	4,633	$20K
82785		<1%	1,921	$20K
92504		<1%	621	$20K
87497		<1%	694	$19K
83615		<1%	5,826	$19K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	30	$19K
88271		<1%	385	$19K
49083		<1%	27	$18K
84425		<1%	1,728	$18K
51600		<1%	43	$18K
87210		<1%	9,085	$18K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	84	$18K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,028	$18K
94729		<1%	1,764	$18K
87081		<1%	4,046	$17K
86704		<1%	2,161	$17K
96136		<1%	150	$17K
86800		<1%	1,337	$17K
84450		<1%	4,170	$17K
73630		<1%	3,409	$17K
87184		<1%	4,276	$16K
86039		<1%	3,172	$16K
86769		<1%	460	$16K
J9045	Injection, carboplatin, 50 mg	<1%	1,214	$16K
84481		<1%	1,928	$15K
83605		<1%	14,465	$15K
97113		<1%	112	$15K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	205	$15K
82627		<1%	681	$15K
87338		<1%	1,707	$15K
72100		<1%	1,824	$15K
80074		<1%	653	$14K
86665		<1%	1,604	$14K
71271		<1%	602	$14K
96523		<1%	140	$14K
85576		<1%	428	$14K
73610		<1%	3,196	$14K
73564		<1%	2,806	$14K
91322		<1%	188	$14K
11721		<1%	408	$13K
99153	Mod sedat endo service >5yrs	<1%	1,424	$13K
73030		<1%	2,762	$13K
86334		<1%	859	$13K
83520		<1%	513	$13K
73590		<1%	2,406	$13K
82550		<1%	4,176	$13K
73110		<1%	2,787	$12K
88275		<1%	141	$12K
87040		<1%	7,702	$12K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	658	$12K
51700		<1%	53	$12K
88108		<1%	264	$12K
87625		<1%	481	$12K
72158		<1%	39	$12K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	311	$11K
43235		<1%	19	$11K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	1,542	$11K
D1120	Dental cleaning, child	<1%	1,853	$11K
82977		<1%	3,287	$11K
82378		<1%	2,337	$11K
D0230	Intraoral - periapical each additional radiographic image	<1%	1,817	$11K
80177		<1%	1,858	$11K
54830		<1%	50	$10K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	614	$10K
80329		<1%	6,871	$10K
72146		<1%	37	$10K
12013		<1%	25	$10K
77338		<1%	43	$10K
83498		<1%	392	$10K
87634		<1%	506	$10K
73090		<1%	2,576	$10K
96137		<1%	149	$10K
83521		<1%	1,346	$10K
92585		<1%	55	$10K
80348		<1%	1,974	$10K
84480		<1%	1,693	$10K
90656		<1%	618	$10K
84165		<1%	1,575	$10K
83010		<1%	1,099	$10K
V2632	Posterior chamber intraocular lens	<1%	165	$9K
82105		<1%	1,689	$9K
0124A		<1%	258	$9K
94010		<1%	636	$9K
95806		<1%	174	$9K
82248		<1%	2,391	$9K
86765		<1%	859	$9K
72040		<1%	1,347	$9K
80164		<1%	1,282	$9K
Q3014	Telehealth originating site facility fee	<1%	1,328	$9K
36000		<1%	293	$8K
95700		<1%	100	$8K
88173		<1%	463	$8K
73080		<1%	2,198	$8K
77075		<1%	77	$8K
86682		<1%	48	$8K
67028	Intravitreal injection of a pharmacologic agent	<1%	118	$8K
76819	Fetal biophysical profile; without non-stress testing	<1%	195	$8K
80320		<1%	5,543	$8K
85613		<1%	1,082	$8K
77301		<1%	41	$8K
83921		<1%	401	$7K
90480		<1%	245	$7K
74019		<1%	1,210	$7K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	25	$7K
90670		<1%	370	$7K
92134		<1%	483	$7K
86355		<1%	304	$7K
85378		<1%	3,545	$7K
85732		<1%	1,187	$7K
76885		<1%	316	$7K
82150		<1%	2,701	$6K
99384		<1%	30	$6K
76978		<1%	12	$6K
73502		<1%	1,130	$6K
86255		<1%	1,142	$6K
99152		<1%	2,026	$6K
77470		<1%	89	$6K
82247		<1%	1,341	$6K
85245		<1%	291	$6K
83020		<1%	609	$6K
85044		<1%	5,048	$6K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	16	$6K
85014		<1%	6,929	$6K
D0220	Intraoral - periapical first radiographic image	<1%	3,007	$6K
99383		<1%	26	$6K
86664		<1%	764	$6K
96401		<1%	104	$5K
99170		<1%	24	$5K
90750		<1%	40	$5K
J9267	Injection, paclitaxel, 1 mg	<1%	268	$5K
96150		<1%	41	$5K
86705		<1%	946	$5K
84154		<1%	547	$5K
84155		<1%	1,739	$5K
D0274	Bitewings - four radiographic images	<1%	2,287	$5K
86708		<1%	807	$5K
86870		<1%	215	$5K
77295		<1%	13	$5K
88142		<1%	212	$5K
90713		<1%	188	$5K
99441		<1%	83	$5K
85246		<1%	344	$5K
90697		<1%	197	$5K
64642		<1%	78	$5K
70543		<1%	12	$5K
73562		<1%	454	$5K
73060		<1%	1,339	$5K
93270		<1%	67	$4K
90680		<1%	541	$4K
96130		<1%	74	$4K
54360		<1%	12	$4K
C1769	Guide wire	<1%	2,270	$4K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	138	$4K
86735		<1%	693	$4K
84703		<1%	4,905	$4K
J9370	Vincristine sulfate, 1 mg	<1%	678	$4K
93017		<1%	110	$4K
97167		<1%	25	$4K
87517		<1%	27	$4K
83993		<1%	414	$4K
85240		<1%	360	$4K
86709		<1%	773	$4K
87799		<1%	110	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	6,509	$4K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	235	$4K
90620		<1%	87	$4K
80175		<1%	558	$4K
G0379	Direct admission of patient for hospital observation care	<1%	76	$4K
94664		<1%	2,029	$4K
96151		<1%	29	$4K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	39	$4K
73700		<1%	14	$4K
82330		<1%	1,142	$4K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	139	$3K
90734		<1%	130	$3K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	867	$3K
73552		<1%	1,166	$3K
90716		<1%	185	$3K
95885		<1%	109	$3K
90472	Immunization administration, each additional vaccine (list separately)	<1%	639	$3K
74455		<1%	15	$3K
46600		<1%	119	$3K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	18	$3K
77072		<1%	286	$3K
90633		<1%	270	$3K
99385		<1%	14	$3K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	14	$3K
84436		<1%	872	$3K
J9070	Cyclophosphamide, 100 mg	<1%	25	$3K
72170		<1%	805	$3K
0002A		<1%	182	$3K
83721		<1%	165	$3K
84590		<1%	254	$3K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	396	$3K
96113		<1%	46	$3K
85384		<1%	1,160	$2K
80183		<1%	350	$2K
82024		<1%	37	$2K
81025		<1%	742	$2K
D7140	Extraction, erupted tooth or exposed root	<1%	112	$2K
88300		<1%	1,099	$2K
85660		<1%	194	$2K
86162		<1%	130	$2K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	38	$2K
78306		<1%	39	$2K
0001A		<1%	167	$2K
82140		<1%	375	$2K
82172		<1%	150	$2K
96376		<1%	3,787	$2K
74230		<1%	28	$2K
72070		<1%	429	$2K
86696		<1%	142	$2K
90746		<1%	94	$2K
73560		<1%	449	$2K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	107	$2K
86617		<1%	187	$2K
82951		<1%	199	$2K
86304		<1%	239	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	13	$1K
J9190	Injection, fluorouracil, 500 mg	<1%	137	$1K
90707		<1%	100	$1K
J2785	Injection, regadenoson, 0.1 mg	<1%	12	$1K
84681		<1%	93	$1K
0012A		<1%	91	$1K
86256		<1%	25	$1K
82525		<1%	145	$1K
86880		<1%	78	$1K
90662		<1%	178	$1K
86592		<1%	889	$1K
78264		<1%	51	$1K
81243		<1%	12	$1K
86357		<1%	54	$1K
87102		<1%	356	$1K
84446		<1%	80	$1K
82157		<1%	44	$1K
82103		<1%	110	$1K
86341		<1%	107	$1K
87468		<1%	31	$1K
86812		<1%	16	$1K
87116		<1%	222	$1K
99406		<1%	12	$1K
97804		<1%	64	$1K
92083		<1%	66	$1K
0004A		<1%	77	$1K
86308		<1%	901	$1K
84630		<1%	175	$959.62
92133		<1%	54	$952.12
84166		<1%	121	$934.15
0011A		<1%	68	$933.07
J3489	Injection, zoledronic acid, 1 mg	<1%	95	$922.77
77290		<1%	14	$877.68
93299		<1%	40	$861.20
87147		<1%	367	$861.05
86148		<1%	151	$791.02
J7120	Ringers lactate infusion, up to 1000 cc	<1%	740	$787.82
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,148	$745.47
C1729	Catheter, drainage	<1%	1,370	$730.86
J2704	Injection, propofol, 10 mg	<1%	8,272	$729.91
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,512	$723.99
0054A		<1%	61	$698.33
87177		<1%	101	$671.28
86301		<1%	112	$669.66
86364		<1%	96	$645.40
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	564	$636.20
86300		<1%	68	$634.54
73070		<1%	218	$599.86
87469		<1%	31	$590.63
87478		<1%	31	$590.63
87484		<1%	31	$590.63
98960		<1%	15	$587.31
87073		<1%	135	$583.31
73100		<1%	197	$575.59
87181		<1%	118	$570.93
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	12	$565.06
90671		<1%	190	$562.15
G0008	Administration of influenza virus vaccine	<1%	323	$560.45
82274		<1%	389	$549.83
87206		<1%	218	$539.50
87015		<1%	332	$489.77
99217		<1%	25	$484.14
C9290	Injection, bupivacaine liposome, 1 mg	<1%	296	$477.19
82390		<1%	64	$456.92
73140		<1%	168	$440.79
84145		<1%	1,076	$424.23
77280		<1%	14	$404.11
87209		<1%	83	$379.98
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,958	$378.04
86922		<1%	18	$375.30
90632		<1%	12	$370.10
82653		<1%	27	$362.90
82787		<1%	29	$359.76
84134		<1%	58	$358.36
86335		<1%	13	$347.01
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,608	$339.19
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,921	$299.98
76820		<1%	26	$296.90
82952		<1%	199	$294.48
J9250	Methotrexate sodium, 5 mg	<1%	171	$291.71
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	14,742	$288.42
72110		<1%	14	$284.66
73120		<1%	67	$271.63
72082		<1%	24	$262.93
82397		<1%	25	$255.51
89051		<1%	167	$253.29
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	62	$244.70
86644		<1%	27	$231.10
86645		<1%	37	$230.71
72202		<1%	25	$229.56
86015		<1%	39	$224.26
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	10,063	$220.07
96131		<1%	72	$219.94
90698		<1%	591	$217.11
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	12	$216.56
89050		<1%	135	$212.21
73521		<1%	38	$210.52
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	6,020	$206.07
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,164	$200.61
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,349	$194.52
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	46	$194.08
99238	Hospital discharge day management, 30 minutes or less	<1%	336	$185.92
90744		<1%	248	$184.74
86707		<1%	12	$169.83
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	252	$167.78
84132		<1%	137	$167.16
A9270	Non-covered item or service	<1%	142	$163.45
88313		<1%	42	$154.73
91321		<1%	41	$145.92
82040		<1%	46	$140.04
82270		<1%	197	$139.18
82232		<1%	14	$139.01
99156		<1%	155	$135.98
J0736	Injection, clindamycin phosphate, 300 mg	<1%	19	$135.20
82668		<1%	12	$121.13
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	696	$110.13
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,443	$105.38
83883		<1%	13	$105.00
82360		<1%	17	$102.89
C2625	Stent, non-coronary, temporary, with delivery system	<1%	26	$97.34
94727		<1%	12	$94.66
J1650	Injection, enoxaparin sodium, 10 mg	<1%	825	$89.46
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,353	$85.34
C1788	Port, indwelling (implantable)	<1%	27	$84.67
A4648	Tissue marker, implantable, any type, each	<1%	486	$84.15
82365		<1%	31	$83.74
J1953	Injection, levetiracetam, 10 mg	<1%	177	$76.50
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	405	$73.62
80178		<1%	13	$69.58
88302		<1%	15	$64.25
82310		<1%	13	$62.21
84295		<1%	48	$61.95
86593		<1%	41	$61.59
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	923	$57.72
J1644	Injection, heparin sodium, per 1000 units	<1%	991	$57.65
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	629	$57.24
70360		<1%	13	$53.16
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	55	$49.22
C9113	Injection, pantoprazole sodium, per vial	<1%	394	$43.73
84520		<1%	14	$43.11
96127		<1%	605	$40.66
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,367	$39.03
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,510	$38.37
73000		<1%	13	$38.17
J3480	Injection, potassium chloride, per 2 meq	<1%	311	$37.20
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	457	$33.92
84157		<1%	69	$32.12
J9260	Injection, methotrexate sodium, 50 mg	<1%	14	$29.99
J3360	Injection, diazepam, up to 5 mg	<1%	71	$29.54
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,175	$26.99
J0780	Injection, prochlorperazine, up to 10 mg	<1%	358	$26.41
85347		<1%	13	$25.06
73600		<1%	29	$22.46
J3370	Injection, vancomycin hcl, 500 mg	<1%	620	$20.69
82945		<1%	41	$19.77
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	<1%	13	$18.57
C2627	Catheter, suprapubic/cystoscopic	<1%	28	$17.85
J7510	Prednisolone oral, per 5 mg	<1%	379	$17.59
J1790	Injection, droperidol, up to 5 mg	<1%	211	$17.40
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	27	$16.30
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	303	$15.26
J1940	Injection, furosemide, up to 20 mg	<1%	137	$14.94
J1170	Injection, hydromorphone, up to 4 mg	<1%	750	$14.36
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	<1%	60	$10.10
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	109	$7.31
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	326	$4.32
J2060	Injection, lorazepam, 2 mg	<1%	587	$3.14
J1836	Injection, metronidazole, 10 mg	<1%	47	$3.00
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	101	$0.96
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	13	$0.33
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	456	$0.18
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	296	$0.04
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	28	$0.03
90473		0%	30	$0.00
99221		0%	15	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	76	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	156	$0.00
C1758	Catheter, ureteral	0%	29	$0.00
J0290	Injection, ampicillin sodium, 500 mg	0%	16	$0.00
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	0%	12	$0.00
0353U		0%	17	$0.00
96159		0%	15	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	25	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	2,548	$0.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	286	$0.00
99417	Prolong home eval add 15m	0%	148	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	183	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	49	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	73	$0.00
J1815	Injection, insulin, per 5 units	0%	80	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	13	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWRIGHT, STUART (CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under WRIGHT, STUART

Full network →

Provider	Location	Paid
SUNY Healthscience Center at Syracuse	Syracuse, NY	$174K
SUNY Health Science Center at Syracuse	Syracuse, NY	$3K
SUNY Health Science Center at Syracuse	Syracuse, NY	$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.